JavaScript is NOT enabled !

Please enable JavaScript.

Article

PubMed

This record comes from PubMed

COVID-19 in 3 patients treated with immune checkpoint inhibitors for advanced melanoma

Arenbergerova, M
Author Arenbergerova, M Department of Dermatovenereology, Third Faculty of Medicine, Charles University and Kralovske Vinohrady University Hospital, Prague, Czech Republic
Gkalpakiotis, S
Author Gkalpakiotis, S ORCID Department of Dermatovenereology, Third Faculty of Medicine, Charles University and Kralovske Vinohrady University Hospital, Prague, Czech Republic
Arenberger, P
Author Arenberger, P Department of Dermatovenereology, Third Faculty of Medicine, Charles University and Kralovske Vinohrady University Hospital, Prague, Czech Republic
Fialova, A
Author Fialova, A Department of Dermatovenereology, Third Faculty of Medicine, Charles University and Kralovske Vinohrady University Hospital, Prague, Czech Republic
Pasek, M
Author Pasek, M Department of Dermatovenereology, Third Faculty of Medicine, Charles University and Kralovske Vinohrady University Hospital, Prague, Czech Republic

The Journal of dermatological treatment. 2022 May ; 33 (3) : 1782-1783. [epub] 20201022

J Dermatolog Treat
ISSN 1471-1753 | 0954-6634
Source

Language English Country Great Britain, England Media print-electronic

Document type Letter

Persistent link https://www.medvik.cz/link/pmid33092421

PubMed 33092421
DOI 10.1080/09546634.2020.1822500
Knihovny.cz E-resources

MeSH
COVID-19 * MeSH
Immune Checkpoint Inhibitors adverse effects MeSH
Humans MeSH
Melanoma * drug therapy MeSH
Skin Neoplasms * drug therapy MeSH
Check Tag
Humans MeSH
Publication type
Letter MeSH
Names of Substances
Immune Checkpoint Inhibitors MeSH

Department of Dermatovenereology 3rd Faculty of Medicine Charles University and Kralovske Vinohrady University Hospital Prague Czech Republic

References provided by Crossref.org

Borrow
RIS

Find record

In BMC

Citation metrics